IP Library Granted Patent US 7,910,221
Granted Patent B2
US 7,910,221 · App. 11/672,867 · Granted Mar 22, 2011

Biocompatible titanium alloys

Assignee: La Jolla Bioengineering Institute
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,910,221
App. No.
11/672,867
Granted
Mar 22, 2011
Kind
B2
Abstract

Methods and compositions are disclosed for coating a biocompatible medical implant with a surface layer having antioxidant activity. In various embodiments, a surface layer described herein destroys the oxidative activity of a reactive oxygen species (ROS) upon contact. An ROS can be, for example, an ROS generated by neutrophils in vivo. In various embodiments, a surface layer comprises a titanium oxide layer that can comprise a rutile, an anatase or a perovskite crystal structure, and can include defects comprising Ti(III). In some embodiments, the oxide layer can further comprise a dopant such as niobium. In some embodiments, methods for forming a surface layer on a biocompatible medical implant having antioxidant activity are disclosed.

Claims (7)

1. An implant comprising a biocompatible material comprising two or more layers where one layer is provided at a surface of the implant and comprising a crystalline titanium oxide having defects comprising Ti(III) comprises of a titanium alloy selected from the group consisting of SrTiO.sub.3 and BaTiO.sub.3.

2. The implant in accordance with claim 1 , wherein the crystalline titanium oxide having a defect comprising Ti(III) further comprises a dopant selected from the group consisting of vanadium, niobium, tantalum, chromium, molybdenum, tungsten, manganese, rhenium, ruthenium, iridium, and a combination thereof.

3. The implant in accordance with claim 2 , wherein the dopant is niobium.

4. The implant in accordance with claim 1 , wherein the titanium alloy further comprises a dopant selected from the group consisting of vanadium, niobium, tantalum, chromium, molybdenum, tungsten, manganese, rhenium, ruthenium, iridium, and a combination thereof.

5. The implant in accordance with claim 1 , wherein the SrTiO.sub.3 is niobium-doped SrTiO.sub.3.

6. The implant in accordance with claim 1 , wherein the crystalline titanium oxide further comprises a perovskite crystal structure.

7. The implant in accordance with claim 1 , wherein the crystalline titanium oxide comprises an anatase crystal structure.

Assignments (5)
CONFIRMATORY LICENSE Recorded Jun 9, 2011
From: LA JOLLA BIOENGINEERING INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026413/0660 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2011
From: FRANGOS, JOHN; SAHLIN, HERMAN; CONTRERAS, RAMIRO
To: LA JOLLA BIOENGINEERING INSTITUTE
Reel/Frame 025729/0355 →
CONFIRMATORY LICENSE Recorded Sep 15, 2009
From: LA JOLLA BIOENGINEERING INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023233/0736 →
CONFIRMATORY LICENSE Recorded Jun 30, 2008
From: LA JOLLA BIOENGINEERING INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021169/0345 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2007
From: CONTRERAS, RAMIRO; SAHLIN, HERMAN; FRANGOS, JOHN A
To: LA JOLLA BIOENGINEERING INSTITUTE
Reel/Frame 018872/0326 →
Continuity (2)
Provisional Application 60771600 · Feb 8, 2006
Related Publication 20070191944A1 · Aug 16, 2007